Latest Stock Market News

The company has reserved equity shares aggregating to Rs 107 crore for its eligible employees who will get a discount of Rs 21 per share during the bidding process.

As of 31-Dec-2021, promoters held 46.86 per cent stake in the company, while FIIs held 10.84 per cent and domestic institutional investors had 4.48 per cent.

Gross margin fell 126 basis points to 43 per cent in Q3FY22. Ebitda margin came in at 23.6 per cent, down 61 basis points over 24.2 per cent last year.

Goldman Sachs said investor focus will be on translation of Paytm’s robust reported GMV growth and disbursals into revenues, as well as further clarity on potential MDR regulations, which has been a key overhang on the stock

Earlier in the quarter, the bank faced allegations of loan ever-greening in the microfinance business it carries out through Bharat Financial Inclusion, a wholly-owned subsidiary.

The company management said on the cost front, the company continued to witness an increase in commodity prices with an inflation of 4 per cent sequentially (quarter on quarter) and 20 per cent over last year.

The Relative Strength Index of the stock stood at 61.0 on Monday.

Marico said it recorded a turnover of Rs 80.5 billion (US $1.1 billion) through its products sold in India and chosen markets in Asia and Africa in the 2020-21 period, reports said.

“For this year, I would like to be underweight on technology unless the valuations become much cheaper and then we take a different view.”

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 198508.98 Crore) operating in Pharmaceuticals sector.